Industry News
Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males
Dec 03, 2011
Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Exercise Benefits Breast Cancer Survivors, Patients With Lymphedema, Say Researchers
Dec 03, 2011
After reviewing published evidence, University of Missouri researchers conclude the benefits of exercise outweigh the risks for breast cancer survivors, including those who develop lymphedema, a chronic swelling that commonly occurs after breast cancer treatment... Read More
New 'Achilles' Heel' In Breast Cancer: Tumor Cell Mitochondria
Dec 03, 2011
Researchers at the Kimmel Cancer Center at Jefferson have identified cancer cell mitochondria as the unsuspecting powerhouse and "Achilles' heel" of tumor growth, opening up the door for new therapeutic targets in breast cancer and other tumor types. Reporting in the online Dec.1 issue of Cell Cycle, Michael P. Lisanti, M.D., Ph.D... Read More
Oral Anticoagulation Treatment Self Monitoring Better Than Conventional Care In Preventing Blood Clots
Dec 02, 2011
A meta-analysis published Online First in The Lancet shows that patients who self-monitor their blood-thinning (oral anticoagulation) therapy with vitamin K antagonists (VKA), such as warfarin, almost halve their risk of developing thromboembolic events like stroke, deep vein thrombosis and heart attack compared with those who receive traditional care... Read More
Tumor-Targeting Compound Points The Way To New Personalized Cancer Treatments
Dec 02, 2011
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients... Read More
Researchers Find New Path To Control Tumor Growth
Dec 02, 2011
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage... Read More
Exercise Benefits Breast Cancer Survivors, Patients With Lymphedema, Say Researchers
Dec 02, 2011
After reviewing published evidence, University of Missouri researchers conclude the benefits of exercise outweigh the risks for breast cancer survivors, including those who develop lymphedema, a chronic swelling that commonly occurs after breast cancer treatment... Read More
Roche's Cobas EGFR Mutation Test For Personalized Treatment Of Non-Small Cell Lung Cancer Receives CE Mark
Dec 02, 2011
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the cobas EGFR Mutation Test is now CE marked for commercial availability in Europe and other countries that recognize CE mark... Read More
New Approach To Graft-Versus-Host Disease Treatment Results In Sustained Improvement For Some Patients
Dec 02, 2011
In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound. The phase I study, published in the Dec... Read More
Soft-Tissue Sarcoma: Unlocking The Genetic And Molecular Mystery
Dec 02, 2011
Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop the growth of these often deadly tumors... Read More
Previous Page Next Page